Richardpruen (talk | contribs) (→Faculty of Public Health (UK): adden new uk report) |
Richardpruen (talk | contribs) (→Office for Health Improvement & Disparities: added (UK) to be clear) |
||
| Line 53: | Line 53: | ||
[[file:FoPH.jpg|center]] | [[file:FoPH.jpg|center]] | ||
== [https://www.gov.uk/government/publications/nicotine-vaping-in-england-2022-evidence-update/nicotine-vaping-in-england-2022-evidence-update-main-findings Office for Health Improvement & Disparities] == | == [https://www.gov.uk/government/publications/nicotine-vaping-in-england-2022-evidence-update/nicotine-vaping-in-england-2022-evidence-update-main-findings Office for Health Improvement & Disparities (UK)] == | ||
[[File:8th evidence review of nicotine vaping in England.png|alt=The report… provides the most robust evidence on health risks of vaping to date. …Vaping poses a small fraction of the risks of smoking. …There is: Significantly lower exposure to harmful substances from vaping compared with smoking, as shown by biomarkers associated with the risk of cancer, respiratory and cardiovascular conditions [and] no significant increase of toxicant biomarkers after short-term secondhand exposure to vaping among people who do not smoke or vape.|border|center|frame|8th evidence review of nicotine vaping in England]] | [[File:8th evidence review of nicotine vaping in England.png|alt=The report… provides the most robust evidence on health risks of vaping to date. …Vaping poses a small fraction of the risks of smoking. …There is: Significantly lower exposure to harmful substances from vaping compared with smoking, as shown by biomarkers associated with the risk of cancer, respiratory and cardiovascular conditions [and] no significant increase of toxicant biomarkers after short-term secondhand exposure to vaping among people who do not smoke or vape.|border|center|frame|8th evidence review of nicotine vaping in England]] | ||
edits